LeMaitre Vascular Inc  

(Public, NASDAQ:LMAT)   Watch this stock  
Find more results for Pruitt
May 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 6.48 - 11.00
Open     -
Vol / Avg. 0.00/69,152.00
Mkt cap 179.84M
P/E 32.57
Div/yield 0.04/1.56
EPS 0.31
Shares 17.55M
Beta -0.13
Inst. own 45%
Jul 27, 2015
Q2 2015 LeMaitre Vascular Inc Earnings Release (Estimated) Add to calendar
Jun 3, 2015
LeMaitre Vascular Inc at Three Part Advisors East Coast IDEAS Investor Conference - 8:40AM EDT - Add to calendar
Apr 28, 2015
Q1 2015 LeMaitre Vascular Inc Earnings Call - Webcast
Apr 28, 2015
Q1 2015 LeMaitre Vascular Inc Earnings Release
Mar 10, 2015
LeMaitre Vascular Inc at ROTH Conference
Feb 25, 2015
Q4 2014 LeMaitre Vascular Inc Earnings Call - Webcast
Feb 25, 2015
Q4 2014 LeMaitre Vascular Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 7.23% 5.51%
Operating margin 12.19% 8.92%
EBITD margin - 14.67%
Return on average assets 6.82% 5.15%
Return on average equity 8.07% 6.28%
Employees 325 -
CDP Score - -


63 2ND AVE
United States - Map
+1-781-2212266 (Phone)
+1-781-4255049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


LeMaitre Vascular, Inc. (LeMaitre Vascular) is a global provider of medical devices and implants for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to addresses the needs of vascular surgeons. The Company's diversified portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart and are well known to vascular surgeons, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch. The Company sells 14 product lines, which are used in open vascular surgery and some of which are used in endovascular procedures. The Company sells its products primarily through a direct sales force. The Company’s products are used by vascular surgeons who treat peripheral vascular disease through both open surgical methods and endovascular techniques.

Officers and directors

George W. LeMaitre Chairman of the Board, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David B. Roberts President, Director
Age: 51
Bio & Compensation  - Reuters
Joseph P. Pellegrino Jr. Chief Financial Officer
Age: 50
Bio & Compensation  - Reuters
Peter R. Gebauer President - International Operations
Age: 61
Bio & Compensation  - Reuters
Trent G. Kamke Senior Vice President - Operations
Age: 44
Bio & Compensation  - Reuters
Cornelia W. LeMaitre Vice President - Human Resources, Director
Age: 79
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Lawrence J. Jasinski Independent Director
Age: 57
Bio & Compensation  - Reuters
John J. O'Connor Independent Director
Age: 67
Bio & Compensation  - Reuters
John A. Roush Independent Director
Age: 50
Bio & Compensation  - Reuters
Michael H. Thomas Independent Director
Age: 63
Bio & Compensation  - Reuters